Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay.
Plos One
Remon, Jordi J; Swalduz, Aurelie A; Planchard, David D; Ortiz-Cuaran, Sandra S; Mezquita, Laura L; Lacroix, Ludovic L; Jovelet, Cecile C; Rouleau, Etienne E; Leonce, Camille C; De Kievit, Frank F; Morris, Clive C; Jones, Greg G; Mercier, Kelly K; Howarth, Karen K; Green, Emma E; Pérol, Maurice M; Saintigny, Pierre P; Besse, Benjamin B
Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition.
Scientific Reports
van Harten, Anne M AM; de Boer, D Vicky DV; Martens-de Kemp, Sanne R SR; Buijze, Marijke M; Ganzevles, Sonja H SH; Hunter, Keith D KD; Leemans, C René CR; van Beusechem, Victor W VW; Wolthuis, Rob M F RMF; de Menezes, Renée X RX; Brakenhoff, Ruud H RH
Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B